It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The phase 2 trial, published Thursday in The Lancet medical journal, looked at the safety and efficacy of seven vaccines given after two initial doses of either the Oxford-AstraZeneca or Pfizer-BioNTech vaccine.
A total of 912 participants experienced adverse events from their booster shot, with 24 severe events being reported during the study.
The research team is now studying the effects of boosters seven to eight months after their initial doses, with results expected in 2022.
originally posted by: zandra
a reply to: HawkEyi
Valneva is the only dead virus vaccine in the line.
The only one I would want to take a booster from. All others: over my dead body. I'm dead serious.
All seven vaccines boosted immunity when given 10 to 12 weeks after two doses of the Oxford-AstraZeneca vaccine, the study found.
Study limitations
However, the study's authors noted that they had not researched how well the different booster combinations worked in terms of preventing transmission, hospitalization and death from Covid. They added that the relationship between antibody levels four weeks on from a booster and long-term immunity remained unknown.
originally posted by: bobs_uruncle
a reply to: HawkEyi
Yep and over a thousand different types of bullets are perfectly safe as well as long as they don't hit people. The jab is perfectly safe as long as it is kept at -80C and never comes out of containment.
Cheers - Dave